Basic Information:
VIRBase ID: HHID00105180
Virus: SARS-CoV-2
Host: Homo sapiens
Confidence Score: 0.9612
Interaction Type: Host-Host interaction
Predicted Binding:
* It may take a few minutes to display results.
Interactor Information:
Interactor1
Interactor2
Symbol
hsa-miR-206
GAK
miRBase Accession/Entrez ID
MIMAT0000462
2580
Organism
Homo sapiens
Homo sapiens
Category
miRNA
mRNA
Alias
-
DNAJ26//DNAJC26
ncRNA SNP information:
Resource
Symbol
SNP ID
SNP Position
Ref/Alt
miRNASNP-v3
hsa-miR-206
RNA Editing:
Resource
Symbol
Editing Position
Change
Genetic Region
RADAR
GAK
Resource
Symbol
Editing Position
Change
SeqReg
exReg
PMID
DARNED
GAK
RNA Modification:
Resource
Symbol
ModificationPosition
Type
Genomic Context
PMID
RMBase
GAK
RNA Localization:
Resource
Symbol
Subcellular Localization
Tissue or Cell Line
PMID
RNALocate
hsa-miR-206
GAK
Related Drug Information:
Resource
Symbol
Drug Name
PubChem ID
Function
Link
RNAInter
hsa-miR-206
Resource
Symbol
Drug Name
PubChem ID
RNAactDrug
hsa-miR-206
Interaction Network (The top 100 interactions) :
Interactor1: hsa-miR-206
Interactor2: GAK
Evidence Support:
Strong-Evidence
Luciferase reporter assay//RT-qPCR//Western blot
Prediction-Evidence
Targetscan
Support Database
ViRBase
References:
PMID
33675361
Target region
3'UTR
Source
ViRBase
Interactor1 expression
Upregulation
Tissue or cell line
786-O cells//HK-2 cells//OS-RC-2 cells
Interactor2 expression
Downregulation
Description
In the current study, available miRNAs that regulate drug targets for treating COVID-19 in clinical trials are summarized in Table 2. miRNAs regulate the clinical targets of SARS-CoV-2 in TTD.